Remdesivir row: COVID-19 drug prompts patent rules debate | 1 July 2020
Remdesivir row: COVID-19 drug prompts patent rules debate | 1 July 2020

Remdesivir row: COVID-19 drug prompts patent rules debate | 1 July 2020

Fify Befe Oa Nana

27 min
News
Play

Description

On this edition of the Sky News Daily podcast with Dermot Murnaghan, we examine the move by the US to buy up global supplies of the drug and its benefits.<br /><br />We are joined by Dr Andrew Hill from the University of Liverpool, who also tells us about other drugs being repurposed to treat patients with the virus.<br /><br />Plus, Hugh Milward from Microsoft and LinkedIn's Josh Graff discuss tectonic shifts in the jobs market as more firms announce cuts - and the launch of their global skills initiative: <a href="https://opportunity.linkedin.com" rel="noopener">https://opportunity.linkedin.com</a><br /><br />Credits:<br />Producer - Annie Joyce<br />Assistant producer - Sabah Choudhry

Uploader

bruce_fox

bruce_fox

Remdesivir row: COVID-19 drug prompts patent rules debate | 1 July 2020 - Listen Free | WowFM